Global Health Limited

NSE: MEDANTA · Hospital · sector

₹1,212.00NSE close 2026-10-26

Key numbers

Market cap₹32,575 cr

Price₹1,212.00

52w high / low₹1,544 / ₹956

P/E58.5xSector median 42.5x

P/B8.2xSector median 4.9x

Book value₹147.4

Dividend yield0.04%Sector median 0.17%

ROE15.1%Sector median 12.1%

ROCE15.8%Sector median 13.8%

OPM20.5%Sector median 20.3%

Debt / equity0.30xSector median 0.24x

EV/EBITDA34.1xSector median 23.6x

Interest cover8.8x

Current ratio2.67x

Sales growth 3y+17.9%Sector median +14.1%

Profit growth 3y+19.5%Sector median +14.7%

PEG3.24x

Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 32 companies in Hospital (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Cash ₹1,130 cr vs borrowings ₹1,190 cr (FY26): borrowings are higher by ₹60 cr.
Operating profit covered interest 8.8x in the last 12 months.
Operating cash flow was below net profit in 0 of the last 4 years.
Revenue was higher than a year earlier in 4 of the last 4 quarters.
Other income was 18% of net profit in the last 12 months.
Debtor days went from 24 (FY24) to 34 (FY26).
Dividend paid in 1 of the last 4 financial years.
Price ₹1,212.00 on 2026-10-26: -21.5% from the 52-week high, +26.8% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹1,506.20 · low ₹969.60

Quarterly results

₹ cr	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	957	943	931	1,031	1,099	1,121	1,159	1,304
EBITDA	228	238	175	247	247	181	244	287
OPM %	23.9%	25.2%	18.8%	23.9%	22.5%	16.1%	21.0%	22.0%
Other income	18	16	23	20	20	22	37	22
Net profit	131	143	101	159	158	95	144	159
EPS (₹)	4.87	5.32	3.77	5.92	5.89	3.54	5.36	5.91
Revenue YoY					+14.9%	+18.8%	+24.5%	+26.5%
Profit YoY					+21.1%	-33.5%	+42.0%	-0.2%

Consolidated figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ cr	FY23	FY24	FY25	FY26	TTM
Revenue	2,694	3,275	3,692	4,410	4,683
EBITDA	612	799	827	918	958
Net profit	326	478	481	556	556
EPS (₹)	12.58	17.80	17.92	20.71	20.70
Revenue growth		+21.6%	+12.7%	+19.4%	+21.3%
Profit growth		+46.6%	+0.7%	+15.6%	+4.1%
Dividend / share (₹)	–	–	–	0.50

Compounded growth	3 years	5 years	Last 12 months
Sales	+17.9%	–	+21.3%
Net profit	+19.5%	–	+4.1%
EPS	+18.1%	–	–
Share price	–	+8.4% (2y)	-11.5%

Balance sheet

₹ cr	FY23	FY24	FY25	FY26
Shareholders' equity	2,428	2,906	3,386	3,962
Borrowings	842	419	328	1,190
Cash & equivalents	1,278	1,175	1,122	1,130
Total assets	4,116	4,304	4,766	5,905
Fixed assets	1,708	1,813	1,975	3,779
Capital work in progress	327	386	529	132
Investments	0	0	3	3
Receivables	194	215	292	411
Inventory	60	67	67	79
Payables	195	187	195	242

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY23	FY24	FY25	FY26
Cash from operations	645	612	624	714
Cash from investing	-342	-441	-721	-1,065
Cash from financing	346	-514	-97	248
Capex	236	279	517	838
Free cash flow	409	334	107	-124

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY23	FY24	FY25	FY26
ROE %	13.4%	16.5%	14.2%	14.0%
ROCE %	16.1%	21.1%	19.2%	15.4%
Debtor days	26	24	29	34
Inventory days	35	32	28	29
Payable days	114	90	81	89
Cash conversion cycle (days)	-53	-34	-24	-26
Working capital days	136	99	90	87

Shareholding

Holder	% (2026-09-30)
Promoters	33.00%
FIIs	9.91%
DIIs	17.01%
of which Mutual funds	15.97%
of which Insurance	0.81%
Government	0.00%
Public (non-institutions)	39.97%

Quarter	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters %	33.03%	33.03%	33.01%	33.01%	33.01%	33.01%	33.00%	33.00%

Promoter group	%
Naresh Kumar Trehan	33.00%
Madhu Trehan	0.00%
Naveen Trehan	0.00%
Neena Malhotra	0.00%
Shyel Trehan	0.00%
Shonan Trehan	0.00%
Aroon Purie	0.00%
Naresh Trehan HUF	0.00%
Insaniyat	0.00%
Medanta Foundation - Poor and Needy Patients Welfare Trust	0.00%
Medanta Institute of Education and Research	0.00%
Naresh Trehan Family Trust	0.00%
NTM Family Trust	0.00%
RKM Family Trust	0.00%
SA Family Trust	0.00%

Public holders above 1%	%
Dunearn Investments (Mauritius) PTE Ltd	14.84%
Sunil Sachdeva	10.04%
RJ Corp Limited	6.58%
Invesco India Business Cycle Fund	5.17%
Kotak Contra Fund	3.43%
Government Pension Fund Global	3.09%
Uti-flexi CAP Fund	2.00%
Polaris Healthcare Investments PTE Ltd	1.86%
Canara Robeco Mutual Fund A/C Canara Robeco Conser	1.72%
HDFC Value Fund	1.11%

1,35,371 shareholders. Pledged: – of promoter shares.

Peers in Hospital

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
APOLLOHOSP	₹1,12,797 cr	54.0x	11.9x	23.6%	21.8%	15.1%	+14.9%	0.26%
MAXHEALTH	₹81,266 cr	55.7x	7.6x	14.5%	13.8%	26.1%	+22.4%	0.18%
MANIPALHOS	₹73,581 cr	–	–	–	–	–	–	–
FORTIS	₹55,467 cr	52.9x	5.6x	11.1%	13.2%	22.2%	+13.2%	0.14%
NH	₹33,971 cr	41.4x	7.5x	20.0%	13.7%	18.7%	+20.4%	0.26%
ASTERDM	₹33,523 cr	104.7x	7.3x	8.0%	12.8%	16.7%	-27.0%	0.16%
MEDANTA	₹32,575 cr	58.5x	8.2x	15.1%	15.8%	20.5%	+17.9%	0.04%
KIMS	₹28,123 cr	131.3x	12.5x	9.3%	9.6%	19.5%	+21.1%	0.74%
AGARWALEYE	₹15,065 cr	101.3x	7.4x	7.6%	16.5%	27.8%	–	0.01%
RAINBOW	₹11,802 cr	41.3x	7.2x	18.3%	27.4%	31.5%	+13.2%	0.26%

All 32 companies in Hospital →

Dividends & corporate actions

Ex-date	Action	Detail
2026-08-14	Dividend	Dividend - Re 0.50 Per Share
2025-08-22	Dividend	Dividend - Re 0.50 Per Share

Documents

Links go to the original files on the exchange website.

About the company

Hospital and Medical Care:


Sector	Healthcare
Industry	Hospital
Sub-industry	Hospital
Symbol	MEDANTA
BSE code	543654
ISIN	INE474Q01031
Face value	₹2.0
Incorporated	2004-08-13
Website	https://www.medanta.org
Plants (India / abroad)	35 / 0

From the company's filings (BRSR FY26).

Data built 2026-10-22 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.